Cefcapene Pivoxil Hydrochloride Is a Potentially New Treatment for Palmoplantar Pustulosis with Pustulotic Arthro-Osteitis

Dermatology

Volumn 231, Issue 4, 2015, Pages 304-311

  Murakami, Masamoto ^a   Masuda, Kana ^a   Utsunomiya, Ryo ^a   Oda, Fumiko ^a   Namba, Chika ^a   Sayama, Koji ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antibiotics; Palmoplantar psoriasis; Palmoplantar pustulosis; Pustular psoriasis; Pustules

Indexed keywords

22 OXACALCITRIOL; ASCORBIC ACID; BETAMETHASONE; C REACTIVE PROTEIN; CEFCAPENE PIVOXIL; CLOBETASOL PROPIONATE; FROPENEM; LOXOPROFEN; MINOCYCLINE; ROXITHROMYCIN; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE;

ADULT; ANTIBIOTIC THERAPY; BACTERIAL FLORA; CASE REPORT; CLOSTRIDIUM BUTYRICUM; DENTAL CARIES; ERYTHEMA; FEMALE; HUMAN; INFLAMMATION; MEDICAL HISTORY; OSTEITIS; PRIORITY JOURNAL; PSORIASIS; PUSTULOSIS PALMOPLANTARIS; PUSTULOTIC ARTHROOSTEITIS; REVIEW; SAPHO SYNDROME; STERNOCLAVICULAR JOINT; STERNOCOSTAL JOINT; VISUAL ANALOG SCALE; ACQUIRED HYPEROSTOSIS SYNDROME; FOOT DERMATOSES; HAND DERMATOSES; MALE; MIDDLE AGED;

ACQUIRED HYPEROSTOSIS SYNDROME; ADULT; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; FEMALE; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; MALE; MIDDLE AGED;

EID: 84947035510     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000439401     Document Type: Review

References (29)

1. Hurtado-Nedelec M, Chollet-Martin S, Nicaise-Roland P, Grootenboer-Mignot S, Ruimy R, Meyer O, Hayem G: Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatology 2008; 47: 1160-1167.
2. Torii H, Nakagawa H, Ishibashi Y: Osteoarthritis in 84 Japanese patients with palmoplantar pustulosis. J Am Acad Dermatol 1994; 31: 732-735.
3. Yamamoto T: Pustulotic arthro-osteitis associated with palmoplantar pustulosis. J Dermatol 2013; 40: 857-863.
4. Ballara SC, Siraj QH, Maini RN, Venables PJ: Sustained response to doxycycline therapy in two patients with SAPHO syndrome. Arthritis Rheum 1999; 42: 819-821.
5. Colina M, Lo Monaco A, Khodeir M, Trotta F: Propionibacterium acnes and SAPHO syndrome: A case report and literature review. Clin Exp Rheumatol 2007; 25: 457-460.
6. Takizawa Y, Murota A, Setoguchi K, Suzuki Y: Severe inflammation associated with synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome was markedly ameliorated by single use of minocycline. Mod Rheumatol 2014; 24: 1015-1018.
7. Schilling F, Wagner AD: Azithromycin: An anti-inflammatory effect in chronic recurrent multifocal osteomyelitis? A preliminary report (in German). Z Rheumatol 2000; 59: 352-353.
8. Wagner AD, Andresen J, Jendro MC, Hulsemann JL, Zeidler H: Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syndrome. Arthritis Rheum 2002; 46: 1965-1968.
9. Kirchhoff T, Merkesdal S, Rosenthal H, Prokop M, Chavan A, Wagner A, Mai U, Hammer M, Zeidler H, Galanski M: Diagnostic management of patients with SAPHO syndrome: use of MR imaging to guide bone biopsy at CT for microbiological and histological work-up. Eur Radiol 2003; 13: 2304-2308.
10. Assmann G, Kueck O, Kirchhoff T, Rosenthal H, Voswinkel J, Pfreundschuh M, Zeidler H, Wagner AD: Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: An interventional study. Arthritis Res Ther 2009; 11:R140.
11. Matzaroglou C, Velissaris D, Karageorgos A, Marangos M, Panagiotopoulos E, Karanikolas M: SAPHO syndrome diagnosis and treatment: report of five cases and review of the literature. Open Orthop J 2009; 3: 100-106.
12. Rozin AP, Nahir AM: Is SAPHO syndrome a target for antibiotic therapy? Clin Rheumatol 2007; 26: 817-820.
13. Bhushan M, Burden AD, McElhone K, James R, Vanhoutte FP, Griffiths CE: Oral liarozole in the treatment of palmoplantar pustular psoriasis: A randomized, double-blind, placebo-controlled study. Br J Dermatol 2001; 145: 546-553.
14. Gladue RP, Bright GM, Isaacson RE, Newborg MF: In vitro and in vivo uptake of azithromycin (CP-62, 993) by phagocytic cells: Possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother 1989; 33: 277-282.
15. Govoni M, Colina M, Massara A, Trotta F: SAPHO syndrome and infections. Autoimmun Rev 2009; 8: 256-259.
16. Alarcon GS: Tetracyclines in the treatment of rheumatoid arthritis. J Clin Rheumatol 1995; 1: 190-193.
17. Greenwald RA: Tetracyclines may be therapeutically beneficial in rheumatoid arthritis. J Clin Rheumatol 1995; 1: 185-189.
18. Greenwald RA: Treatment of destructive arthritic disorders with MMP inhibitors. Potential role of tetracyclines. Ann NY Acad Sci 1994; 732: 181-198.
19. Nip LH, Uitto VJ, Golub LM: Inhibition of epithelial cell matrix metalloproteinases by tetracyclines. J Periodont Res 1993; 28: 379-385.
20. Golub LM: Reduction with tetracyclines of excessive collagen degradation in periodontal and other diseases. NY State Dent J 1990; 56: 24-26.
21. Greenwald RA, Moak SA, Ramamurthy NS, Golub LM: Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen ameliorate bone damage. J Rheumatol 1992; 19: 927-938.
22. Yu LP Jr, Smith GN Jr, Brandt KD, Myers SL, O'Connor BL, Brandt DA: Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum 1992; 35: 1150-1159.
23. Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL, et al: Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 1994; 370: 555-557.
24. McGeehan GM, Becherer JD, Bast RC Jr, Boyer CM, Champion B, Connolly KM, Conway JG, Furdon P, Karp S, Kidao S, et al: Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature 1994; 370: 558-561.
25. Rudwaleit M, van der Heijde D, Landewe R, Akkoc N, Brandt J, Chou CT, Dougados M, Huang F, Gu J, Kirazli Y, Van den Bosch F, Olivieri I, Roussou E, Scarpato S, Sorensen IJ, Valle-Onate R, Weber U, Wei J, Sieper J: The assessment of Spondyloarthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011; 70: 25-31.
26. Yamamoto T, Kimura K, Katayama I, Nishioka K: Successful treatment of severe arthralgia associated with palmoplantar pustulosis with low-dose oral cyclosporine A. J Dermatol 1995; 22: 512-514.
27. Vaccaro M, Borgia F, Guarneri F, Blandino A, Cannavo SP, Guarneri B: Successful treatment of pustulotic arthro-osteitis (Sonozaki syndrome) with systemic cyclosporin. Clin Exp Dermatol 2001; 26: 45-47.
28. Hayama K, Inadomi T, Fujisawa D, Terui T: A pilot study of medium-dose cyclosporine for the treatment of palmoplantar pustulosis complicated with pustulotic arthro-osteitis. Eur J Dermatol 2010; 20: 758-762.
29. Akiyama T, Seishima M, Watanabe H, Nakatani A, Mori S, Kitajima Y: The relationships of onset and exacerbation of pustulosis palmaris et plantaris to smoking and focal infections. J Dermatol 1995; 22: 930-934.